Polypeptides
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 15, 2015
Grant Date -
Jun 12, 2014
app pub date -
Jul 8, 2011
filing date -
Jul 9, 2010
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present disclosure relates to a class of engineered polypeptides having a binding affinity for albumin. It also relates to new methods and uses that exploit binding by these and other compounds to albumin in different contexts, some of which have significance for treatment or diagnosis of disease in mammals including humans.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully